Clayton, Dubilier & Rice Names Manfred Schneider, Former Bayer Chairman, as an Advisor

Clayton, Dubilier & Rice Names Manfred Schneider, Former Bayer Chairman, as an

PR Newswire

LONDON and NEW YORK, Oct. 1, 2012

LONDON and NEW YORK, Oct. 1, 2012 /PRNewswire/ --Clayton, Dubilier & Rice
today announced that Dr. Manfred Schneider, former Chairman of the Supervisory
Board of Bayer AG, the global pharmaceutical company, has become a CD&R

In a career that has spanned over 45 years at Bayer, Dr. Schneider held a
number of positions including Chairman of the Board of Management and Chairman
of the Supervisory Board. Dr. Schneider is also on the Supervisory Boards of
Linde AG, the industrial engineering company and RWE AG, the utility company.

During his decade-long tenure as Management Board Chairman, Dr. Schneider
succeeded in expanding Bayer's global market position consistently for ten
years, achieving record financial results. During this period, Bayer's market
capitalization grew by about 200 percent. While CEO, Dr. Schneider focused on
expanding Bayer's research and development activities. He was also
responsible for significant international expansion and bolstering the
company's positions in North American and Asian markets. 

"We are delighted to welcome Manfred to the Firm," said Donald J. Gogel,
Chairman and Chief Executive Officer of CD&R. "He is an exceptional global
industrial leader with a track record of driving growth and innovation across
three continents."

"CD&R's approach combining investment judgment and operational expertise is
very compelling to me and has particular relevance to European companies
seeking to respond to an uncertain and challenging economic environment," said
Dr. Schneider. "I look forward to working with a Firm that is one of the true
pioneers of the industry."

About Clayton, Dubilier & Rice

Founded in 1978, Clayton, Dubilier & Rice is a private equity firm with an
investment strategy predicated on building stronger, more profitable
businesses. CD&R has managed the investment of approximately $18 billion in 52
businesses representing a broad range of industries with an aggregate
transaction value of more than $80 billion. The Firm has offices in New York
and London. For more information, please visit


Daniel G. Jacobs
Clayton, Dubilier & Rice

SOURCE Clayton, Dubilier & Rice

Press spacebar to pause and continue. Press esc to stop.